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Background: The Overall Depression Severity and Impairment Scale (ODSIS) is a
self-report scale designed to evaluate the severity and functional impairment associated
with depression.
Objective: This study evaluated the psychometric properties of the online version of the
ODSIS in Spanish outpatients with depression and anxiety disorders.
Method: Patients with a main diagnosis of a depressive (n = 283) or anxiety disorder
(n= 191) and a mean age of 38.15 (SD= 12.06) were evaluated with a clinical diagnostic
interview and measures assessing depression, anxiety, positive and negative affect,
and quality of life. Factorial structure, internal consistency, convergent, and discriminant
validity and cutoff scores were analyzed.
Results: Consistent with previous validations of the instrument, Confirmatory Factor
Analysis showed a unidimensional factor structure. Furthermore, the results obtained
supported the internal consistency and construct validity of the ODSIS scores. A score
of 5 was found to meet the criteria used in this study for the optimal cutoff score.
Conclusion: The results obtained in this study show that the Spanish version of the
ODSIS delivered online is an adequate tool to assess the depression-related severity
and impairment in a brief and easy fashion.
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INTRODUCTION
Among the emotional disorders, the most prevalent lifetime
syndrome is a major depressive episode (1, 2). It is among
the most common reasons for consulting a general practitioner
(3–5). This happens not only in adult’s population, but also
among young people the major depressive disorder (MDD) is
considered one of the leading causes of disability (6–9). In Spain,
depression is the most pervasive mental disorder, with a 12-
month prevalence estimated at 3.9%, and a lifetime prevalence
estimated at 10.5% (6). To the epidemiological magnitude
of this disease, it is important to add its special tendency
toward chronicity (7) and its high rate of comorbidity (10),
especially with anxiety disorders (11). Moreover, research has
shown that depression is associated with significant functional
impairment, with poorer quality of life, disability, and important
costs (personal, social, and economic) (2, 10, 12). Furthermore,
regarding the functioning domains, depressive symptoms have
stronger associations with role limitations due to vitality, mental
health, physical and emotional, and social functioning problems
than anxiety symptoms (2). In view of these data, there is
a need to develop screening strategies for the emotional and
behavioral symptoms related to MDD (6, 13). Furthermore,
because depressive symptoms are accompanied by significant
distress and impairment, it is important to capture the severity
of the impairment and assess it in research and clinical settings.
With the increasing interest in the identification and
dissemination of evidence-based treatments for psychological
problems, the need for evidence-based assessment strategies
is greater than ever before. It is crucial for researchers
to develop assessment instruments with good psychometric
properties resulting in their reliable evaluation. Furthermore,
because research on Internet-based interventions has grown
exponentially in recent years, it is also necessary to validate online
assessment scales with good psychometric properties (14, 15).
As mentioned above, depression is among the most prevalent
and disabling psychological disorders worldwide. Currently, a
variety of well-validated measures exist to assess different aspects
of depression, such as the Patient Health Questionnaire-9 [PHQ-
9; (16)], the Center for Epidemiological Studies Depression Scale
[CES-D; (17)], and the Beck Depression Inventory-II [BDI-II;
(18)]. Nevertheless, the existing depression scales are lengthy and
Abbreviations: AUC, area under the curve; BAI, Beck Anxiety Inventory; BDI-
II, Beck Depression Inventory-II; CES-D, Center for Epidemiological Studies
Depression Scale; CFA, Confirmatory Factor Analysis; CFI, comparative fitness
index; CTT, Classical Test Theory; CZ, Criterion, and Concordance Probability
Method; DSM-IV-TR, Statistical Manual of Mental Disorders Fourth Edition;
DSM-5, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition;
GAD, Generalized anxiety disorder; IU, Index of Union; J, Youden index;
MINI, Mini-International Neuropsychiatric Interview; NPV, Negative Predictive
Value; OASIS, Overall Anxiety Severity and Impairment Scale; ODSIS, Overall
Depression Severity and Impairment Scale; OCD, Obsessive-compulsive disorder;
PANAS, Positive and Negative Affect Schedule; PANAS-N, Positive and Negative
Affect Schedule-Negative Affect; PANAS-P, Positive and Negative Affect Schedule-
Positive Affect; PD/AG, Panic disorder/agoraphobia; PHQ-9, Patient Health
Questionnaire-9; PPV, Sensitivity, Specificity, Positive Predictive Value; QLI,
Multidimensional Quality of Life Questionnaire; RMSEA, root mean square error
or approximates; SAD, Social anxiety disorder; ROC curve, receiver operating
characteristic; SRMR, Standardized root mean residuals.
largely focused on the frequency of cognitive, affective, or somatic
symptoms related to depression, rather than overall severity and
the resulting impairment.
The literature shows that it is essential to assess the
severity and impairment associated with depression because
these factors influence whether or not individuals may benefit
from treatment (19). Thus, because depression usually leads
to important impairments, it is necessary to measure this
aspect (i.e., how depression affects a patient’s daily life
and interpersonal relationships) in order to determine the
effectiveness of an intervention (18). Indeed, according to the
Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition (DSM-5) (20), functional impairment is a basic criterion
in depressive disorders.
The Overall Depression Severity and Impairment Scale
(ODSIS) is a 5-item assessment instrument to evaluate severity
and functional impairment due to depressive symptoms, such
as the frequency and intensity of depression and its interference
with work, school, social life, and relationships. Furthermore, it
also assesses the impairment caused by depression-related loss
of interest and difficulty engaging in activities (20). All of these
questions are rated on a Likert-type scale ranging from 0 to 4 and
referring to an “in the past week” time frame, with higher scores
indicating greater depression-related severity and impairment.
To date, only two validation studies of the ODSIS have been
published. The first validation of the ODSIS was conducted in a
North American sample (19), whereas the second was performed
in a non-western sample (21). Both validations showed good
psychometric properties, such as optimal internal consistency
and adequate convergent and discriminant validity. Among the
advantages of the ODSIS, the authors highlighted its accuracy
in detecting depressive disorders, in spite of its conciseness, and
the fact that the scale focuses on general functional impairment
rather than specific symptoms (19, 21).
To the best of our knowledge, no study has evaluated the
psychometric properties of the online version of the ODSIS
in a sample of adults with depression and anxiety disorders
in the Spanish population. In addition, although an online
validation of the ODSIS has already been carried out (21), the
diagnoses of the participants in this study were based on their
own self-reports, rather than well-validated instruments such as
diagnostic interviews, as in the present study. Specifically, the
participants were asked whether they were “diagnosed as having
major depressive disorder and being treated for the problem in a
medical setting” [(21), p. 4].
In a previous study published by the current authors, the
psychometric properties of the Overall Anxiety Severity and
Impairment Scale (OASIS) were analyzed (22). Similarly to the
ODSIS, the OASIS is a 5-item scale for the assessment of the
severity and impairment associated with anxiety. Therefore,
using the same pool of individuals, in this study, we explored
the psychometric properties of the ODSIS in two clinical
subsamples of Spanish individuals with emotional disorders:
a subsample with a principal diagnosis of depression (n =
283) and a subsample with a principal diagnosis of anxiety (n
= 191). Thus, we formulated the following objectives: (a) to
examine how the scale performs in patients with depressive vs.
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anxiety disorders; (b) to examine the scale’s internal structure,
reliability, and validity of the test scores; and (c) to obtain a
cutoff score.
METHODS
Procedure
The procedure in the present study was the same than in
the recently published study regarding the Spanish validation
of the OASIS (22). Before starting the study, a translation of
the scale from English to Spanish was performed using the
procedure described in González-Robles et al. (22). Individuals
who were waiting to receive an online psychological treatment
at the Emotional Disorders Clinic (Universitat Jaume I) were
informed that a research study was being conducted, and
they were invited to participate. Participants who agreed to
participate, that were 18 years old, signed an informed, written
consent, and met Diagnostic and Statistical Manual of Mental
Disorders Fourth Edition (DSM-IV-TR) (23) criteria for a
principal diagnosis of an emotional disorder (i.e., anxiety or
depressive disorder) were considered for the study. DSM-IV-
TR diagnoses were ascertained using the MINI-International
Neuropsychiatric Interview (MINI) (24) by doctoral students
who had been previously trained in the use of the diagnostic
interview. Following the administration of the interview, the
participants completed an online battery of questionnaires on
depression, anxiety, positive and negative affect, and quality of
life. All these measurement instruments are described in the
Instruments section. Ethical approval for the research study was
obtained from the Ethics Committee of Universitat Jaume I.
Participants
A total of 474 individuals participated in the study. As
aforementioned, we included the same participants that took
part in the recent Spanish validation of the OASIS. However,
the number of participants in the present study is lower
because a portion of the sample did not answer the ODSIS.
The average age was 38.15 (SD = 12.06; range: 18–68 years),
and women made up the majority of the sample (n = 342;
72.15%). Most participants were married or had partners (n
= 242; 51.05%), and about half had completed university
studies (n = 235; 49.58%). In all, 283 participants had a main
diagnosis of a depressive disorder (i.e., major depressive disorder,
dysthymic disorder, depression not otherwise specified), and
191 had a main diagnosis of an anxiety disorder. The sample
had a high comorbidity rate, with more than half of the
participants (57.81%) presenting with at least one comorbid
anxiety and/or depressive disorder. Table 1 summarizes
participants’ sociodemographic and clinical characteristics.
Furthermore, Supplementary Datasheet 1 has the demographic
and clinical data.
Instruments
Diagnostic Interview
Mini-international neuropsychiatric interview (24)
The MINI is a brief, structured diagnostic psychiatric interview
that yields DSM-IV and ICD-10 diagnoses. The interview has
TABLE 1 | Sociodemographic and clinical features of the sample (N = 474).
Age in years, Mean (SD) 38.15 (12.06)
SEX, n (%)
Female 342 (72.2)
Male 132 (27.8)
RELATIONSHIP STATUS, n (%)
Single 174 (36.7)
Married/de facto 242 (51.1)
Divorced 52 (11.0)
Widowed 6 (1.3)
EDUCATION LEVEL, n (%)
Basic 81 (17.1)
Medium 158 (33.3)
University 235 (49.6)
PRINCIPAL DIAGNOSIS, n (%)
Major depressive disorder (MDD) 273 (57.6)
Generalized anxiety disorder (GAD) 76 (16.0)
Social anxiety disorder (SAD) 44 (9.3)
Panic disorder/agoraphobia (PD/AG) 43 (9.1)
Obsessive-compulsive disorder (OCD) 15 (3.2)
Anxiety NOS 10 (2.1)
Dysthymic disorder 8 (1.7)
Posttraumatic stress disorder (PTSD) 3 (0.6)
Depression NOS 2 (0.4)
NUMBER OF COMORBID DISORDERS, n (%)
0 200 (42.2)
1 184 (38.8)
2 69 (14.6)
≥ 3 21 (4.4)
SYMPTOM SEVERITY, MEAN (SD)
ODSIS 7.83 (4.90)
BDI-II 23.08 (10.97)
BAI 19.95 (12.01)
OASIS 8.73 (4.22)
PANAS-N 25.91 (8.00)
PANAS-P 20.94 (7.23)
QLI 4.92 (1.67)
ODSIS, Overall Depression Severity and Impairment Scale; BDI-II, Beck Depression
Inventory-II; BAI, Beck Anxiety Inventory; OASIS, Overall Anxiety Severity and Impairment
Scale; PANAS-N, Positive and Negative Affect Schedule-Negative Affect; PANAS-P,
Positive and Negative Affect Schedule-Positive Affect; QLI, Multidimensional Quality of
Life Questionnaire.
shown excellent interrater and test-retest reliability. The Spanish
validation of the MINI was employed in this study (25).
Self-Reported Questionnaires
Overall depression severity and impairment scale
(ODSIS) (19)
The ODSIS is a brief self-reported scale with 5 items that
assess the severity and functional impairment associated with
depressive symptoms. Items are coded on a 5-point scale (0–4).
The sum of the scores is used to obtain the total score, which
can be a maximum of 20. The measure has shown excellent
internal consistency (α = 0.94 in an outpatient sample, 0.92
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in a community sample, and 0.91 in a student sample) and
good convergent/discriminant validity (21). In the present study,
Cronbach’s alpha for the ODSIS was excellent (α= 0.93).
Beck depression inventory (BDI-II) (18)
The BDI-II is one of the most widely used scales for the
assessment of depressive symptoms. The scale is made up of
21 items, rated from 0 to 3, about the different symptoms
characterizing major depression disorder. The sum of the scores
is used to obtain the total score, which can be a maximum of 63
points. The BDI-II has shown good internal consistency (α =
0.76–0.95). The Spanish validation has also demonstrated high
internal consistency for both general (α = 0.87) and clinical
populations (α = 0.89) (26). In the current study, the internal
consistency of the BDI-II was excellent (α= 0.90).
Beck anxiety inventory (BAI) (27)
The BAI is a 21-item self-reported questionnaire that evaluates
anxiety symptoms in a past week timeframe. Each item is rated
from 0 (“not at all”) to 3 (“severely”), and scores can range
between 0 and 63 points. The BAI has shown good to excellent
internal consistency in previous validations (Cronbach’s alpha
between 0.85 and 0.94), as well as adequate convergent and
divergent validity (28). In the current study, Cronbach’s alpha for
the BAI was excellent (α= 0.91).
Overall anxiety severity and impairment scale (OASIS) (29)
The OASIS is a 5-item self-reported scale that assesses the
severity, impairment (work and social), and behavioral avoidance
caused by anxiety symptoms. Previous studies have shown
good internal consistency (α = 0.80), test-retest reliability,
and convergent and discriminant validity (29–31). The Spanish
version of the OASIS showed good internal consistency
(α = 0.86), convergent and discriminant validity, as well as
sensitivity to change (16). Cronbach’s alpha for the OASIS in the
present study was good (α= 0.86).
Positive and negative affect schedule (PANAS) (32)
The PANAS is a scale that evaluates two independent dimensions
of affect: positive affect (PANAS-P) and negative affect (PANAS-
N). Each subscale is made up of 10 items with descriptors (e.g.,
“scared” or “anxious” for the PANAS-N; “active” or “inspired”
for the PANAS-P), and individuals have to select the degree to
which they have experienced each of them in the past week on a 5-
point Likert scale, with total scores ranging from 10 to 50 points.
This measure has shown excellent convergent and divergent
validity, as well as high reliability indexes (32, 33). In this study,
Cronbach’s alphas for this instrument were good to excellent (α
= 0.88 for the PANAS-N and α= 0.93 for the PANAS-P).
Multidimensional quality of life questionnaire (QLI) (34)
The QLI is a 10-item self-reported scale assessing the following
areas regarding quality of life: psychological well-being, physical
well-being, self-care and independent functioning, occupational
functioning, interpersonal functioning, emotional and social
support, community and service support, self-realization,
spiritual satisfaction, and a global assessment of quality of life.
Previous psychometric evaluations of the QLI have found good
internal consistency and test-retest reliability (34, 35). In the
current study, Cronbach’s alpha was good (α= 0.89).
Data Analysis
We followed the same statistical procedures for the analyses of
data as in González-Robles et al. (22). First, descriptive statistics
for the depression and anxiety subsamples were calculated for the
ODSIS. In addition, an analysis of outliers was conducted with
the ODSIS and BDI-II scores, such that a score was considered
an outlier if it deviated from the median more than 1.5 times
the interquartile range (36). Second, one-way ANOVAs were
performed to compare the total scores on the ODSIS according
to gender, relationship status, studies and principal diagnosis,
and number of comorbid diagnoses. Bivariate correlations were
calculated to analyze whether there was any association between
age and ODSIS scores. In addition, reliability was analyzed by
calculating internal consistency indexes (Cronbach’s alpha) for
the five items on the ODSIS.
As in González-Robles et al. (22), the latent structure of the
ODSIS was analyzed using Confirmatory Factor Analysis (CFA),
a method based on Classical Test Theory (CTT) (37). Maximum
likelihood estimation and robust corrections were used to
estimate the CFA models, given the scale’s non-normality and
five-point response scale. Full InformationMaximum Likelihood
was employed to handlemissing data. Following the validation by
Bentley et al. (19), a unidimensional factor structure was tested as
the basis for the CFA model. A number of criteria were used to
assess model fit: the chi-square test (χ2), the comparative fitness
index (CFI), standardized root mean residuals (SRMR), and the
rootmean square error or approximates (RMSEA). The following
cutoff scores were used to determine good fit: CFI and TLI above
0.90 (better if above 0.95) and RMSEA below.08 (38–40).
To examine construct validity of the test scores, the
ODSIS was correlated with measures of anxiety (OASIS, BAI),
depression (BDI-II), positive and negative affect (PANAS-P and
PANAS-N) and quality of life (QLI). To interpret the correlation
values, Cohen’s (41) recommendations were followed: effect sizes
between 0.10 and 0.30 are small; between 0.30 and 0.50 are
medium; and 0.50 or above are large.
To assess the sensitivity and specificity of the ODSIS scores
in detecting depressive symptoms, participants were classified
according to published cutoffs of the BDI-II, so that patients
with scores below 14 were considered to do not have zero or
minimal depressive symptoms, while those with scores equal
or above 14 to have mild, moderate or severe depressive
symptoms (18). To examine the precision of the ODSIS scores
in detecting cases with and without depressive symptoms, the
receiver operating characteristic (ROC) curve and the area under
the curve (AUC) were calculated. A 95% confidence interval
for the AUC and its statistical significance were also calculated
(42). In addition, Sensitivity, Specificity, Positive Predictive Value
(PPV), and Negative Predictive Value (NPV) were obtained
for each ODSIS cutoff point around the range of scores. In
order to identify the optimal cutoff point on ODSIS scores to
offer the best balance between sensitivity and specificity, four
different methods were applied to each ODSIS cutoff point:
Youden index (J), Index of Union (IU), Closest to (0, 1)
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Criterion, and Concordance Probability Method (CZ) (43). The
ODSIS score that met the four criteria, or most of them, was
selected as the optimal cutoff point. A detailed description of
the statistical procedures followed in this study can be found in
González-Robles et al. (22).
The following software was employed for the analyses. CFA
was calculated using the software EQS (version 6). The sensitivity,
specificity, PPV, NPV, and their 95% confidence intervals were
calculated using the web application http://vassarstats.net/clin1.
html. The remaining analyses were performed through the
software SPSS Statistics, version 22.0.
RESULTS
Preliminary Analyses
The mean ODSIS score was 7.83 (SD = 4.90) for the total
sample (n = 474), 7.94 (SD = 4.98) for females (n = 342),
and 7.53 (SD = 4.67) for the male participants (n = 132).
Means and standard deviations for each item and the total score
on the ODSIS are shown in Table 2 for both the depressive
and anxiety disorder samples. The analyses of outliers for the
ODSIS and the BDI-II with interquartile range did not show
the presence of scores that can be considered as outliers. No
significant differences were found based on gender (d= 0.08) and
marital status (Eta2 = 0.012). A slight but significant correlation
between age and the ODSIS scores was observed (r = 0.09, p <
0.05). The scores on the ODSIS in the depression sample were
significantly higher than those in the anxiety sample [F(1, 472) =
22.76; p< 0.001; d = 0.45]. Additionally, statistically significant
differences in the ODSIS scores were found as a function
of education level [F(2, 471) = 5.43; p< 0.01; Eta
2
= 0.023].
Sidak’s post-hoc tests showed significant differences in depression
levels in patients with medium studies compared to those with
university studies, with lower levels of depression in the latter
(p< 0.01). Significant differences were also found depending
on the principal diagnosis [F(8, 465) = 4.23; p< 0.001; Eta
2
=
0.068] and number of comorbid disorders [F(3, 470) = 5.71; p<
0.01; Eta2 = 0.035]. Sidak’s post-hoc tests showed that patients
with MDD as the principal diagnosis were significantly more
depressed than patients with PD/AG as the principal diagnosis
(p< 0.01). Additionally, post-hoc tests revealed that patients with
3 or more comorbid diagnoses had significantly higher levels of
depression than those without any comorbid disorder (p<0.05).
Factor Structure
Adequate model fit was found for a single-factor model, with the
following values: χ2(4) = 16.08, p> 0.001; SRMR= 0.03, RMSEA
= 0.08, 90% CI (0.04, 0.12); CFI = 0.99. All items were strongly
related to this factor, as shown by the factor loadings, with values
that ranged from 0.84 to 0.88.
Internal Consistency
Cronbach’s alpha for the five items on the ODSIS was 0.92.
Table 3 displays the results for Cronbach’s alpha when omitting
items, corrected correlations between each item, and the total
score, and correlations between the five items of the ODSIS. The
outcomes indicate good internal consistency of the ODSIS scores
that would not be increased by excluding any item.
Convergent and Discriminant Validity
Table 4 summarizes the correlation coefficients between the
ODSIS and convergent and discriminant measures. A large
and positive correlation between the ODSIS and the BDI-II
was expected. A positive but medium correlation was expected
between the ODSIS and the anxiety measures (OASIS and
BAI). Furthermore, given that the PANAS and the BDI-II assess
different but related constructs (44), a positive but medium
correlation between the ODSIS and the PANAS-N, and a negative
but medium correlation between the ODSIS and the PANAS-P
were expected. Finally, because quality of life is highly dependent
on psychological well-being (45), a negative, medium to high
correlation between the ODSIS and the QLI was predicted.
Weaker correlations between theODSIS andmeasures of anxiety,
positive/negative affect, and quality of life than with depression
measures were interpreted as evidence for discriminant validity
of the test scores.
The ODSIS significantly correlated with all the measures. A
positive and large correlation between the ODSIS and the BDI-
II was found, as expected (r = 0.67, p < 0.01). Furthermore,
medium and positive correlations were observed between the
ODSIS and the anxiety measures (OASIS and BAI), with values
ranging between 0.37 and 0.47 (p< 0.01). In addition, the ODSIS
correlated negatively but highly with the PANAS-P (r = −0.56,
p < 0.01), and positively but moderately with the PANAS-N
(r = 0.49, p < 0.01). Finally, a large and positive correlation
was observed between the ODSIS and the QLI (r = 0.70,
p< 0.01).
ROC Analysis
A ROC curve was calculated in the sample of 136 participants.
Not all the participants of the sample completed the BDI-
II measure at pre-test. For this reason, we did the analysis
with 136 participants. The scores on the BDI-II were used as
criterion, such that participants with scores ≥ 14 on the BDI-
II were classified as suffering from mild, moderate or severe
depressive symptoms, whereas participants with scores below
14 were classified as suffering from zero or minimal depressive
symptoms (18). The AUC obtained was 0.84 (95%CI: 0.76 and
0.91) and reached statistical significance (p < 0.001). Figure 1
TABLE 2 | Descriptive statistics for each item and the total score on the ODSIS in
depression and anxiety samples.
Depression (n = 283) Anxiety (n = 191)
M SD M SD
Item 1 1.80 1.03 1.43 1.09
Item 2 1.67 0.95 1.30 1.02
Item 3 1.88 1.16 1.40 1.17
Item 4 1.65 1.09 1.24 1.30
Item 5 1.69 1.11 1.25 1.18
Total score 8.69 4.68 6.55 4.94
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TABLE 3 | Cronbach’s alpha if item is deleted, corrected item-total score correlation, and correlations between items.
Cronbach’s alpha if item deleted Corrected item-total correlation Correlations between items
Item 1 Item 2 Item 3 Item 4 Item 5
Item 1 0.906 0.800 1
Item 2 0.907 0.801 0.776* 1
Item 3 0.898 0.836 0.722* 0.707* 1
Item 4 0.912 0.771 0.659* 0.677* 0.723* 1
Item 5 0.905 0.803 0.686* 0.683* 0.780* 0.687* 1
*All correlations were statistically significant at p < 0.01 (2-tailed).
TABLE 4 | Correlations of the ODSIS with convergent validity measures.
ODSIS BDI-II BAI OASIS PANAS-N PANAS-P QLI
ODSIS 1 0.67* 0.37* 0.47* 0.49* −0.56* −0.70*
BDI-II 1 0.44* 0.47* 0.55* −0.54* −0.77*
BAI 1 0.62* 0.55* −0.25* −0.41*
OASIS 1 0.42* −0.29* −0.56*
PANAS-N 1 −0.27* −0.47*
PANAS-P 1 0.71*
QLI 1
*All correlations were statistically significant at p < 0.01 (2-tailed).
ODSIS, Overall Depression Severity and Impairment Scale; BDI-II, Beck Depression
Inventory-II; BAI, Beck Anxiety Inventory; OASIS, Overall Anxiety Severity and Impairment
Scale; PANAS-N, Positive and Negative Affect Schedule-Negative Affect; PANAS-P,
Positive and Negative Affect Schedule-Positive Affect; QLI, Multidimensional Quality of
Life Questionnaire.
displays a graphical representation of the ROC curve. This AUC
can be interpreted as indicating that there was a 0.84 probability
of randomly selecting a participant from the mild, moderate or
severe depressive symptoms group (i.e., with a BDI-II score≥ 14)
with an ODSIS score higher than that of any other participant,
also randomly selected, from the zero or minimal depressive
symptoms group (i.e., with BDI-II score < 14). An AUC =
0.84 can be interpreted as reflecting moderate precision from
a clinical point of view. Therefore, the precision of the ODSIS
scores in detecting depressive symptoms can be considered to
have a moderate magnitude.
Table 5 presents the sensitivity, specificity, PPV, and NPV
obtained with the ODSIS scores for the cutoff point ≥ 14 on the
BDI-II. Table 5 also shows the results obtained from applying
four methods to select the optimal cutoff point for the ODSIS
scores [Youden index, J, Index of Union, IU, the Closest to (0,
1) Criteria, ER, and the Concordance Probability Method, CZ].
Out of the four methods, the ODSIS score = 5 met three of the
four criteria (IU, ER, and CZ criteria), and on the Youden index,
this score obtained the second-best value, very close to the first
one. Therefore, the optimal selected cutoff point on the ODSIS
was 5 (i.e., ODSIS scores ≥ 5 indicating depressive symptoms).
For this cutoff point, sensitivity was 0.74 (95%CI: 0.64 and
0.82), whereas specificity was 0.80 (95%CI: 0.63 and 0.91). PPV
was 0.92 (95%CI: 0.83 and 0.97), and NPV was 0.52 (95%CI:
0.38 and 0.66; see bold values provided in Table 5).
FIGURE 1 | ROC curve.
DISCUSSION
The aim of this study was to analyze the psychometric properties
of the ODSIS administered online in a Spanish sample of
patients with depression and anxiety disorders. The literature has
shown the high comorbidity rates between depressive and anxiety
disorders (10); therefore, it is important to explore how the scale
performs in both diagnostic groups. To our knowledge, this is the
first study to evaluate its psychometric properties in a Spanish
clinical sample using the online version of the instrument. This
study evaluated the reliability and construct validity of the test
scores, latent structure, and cutoff scores of the ODSIS.
First, preliminary analyses showed no significant differences
based on gender or marital status. However, patients with
medium studies were significantly more depressed than those
with university studies. In addition, a slight but significant
correlation was observed between age and the ODSIS scores.
By contrast, the original validation did not find significant
differences with regard to any sociodemographic or clinical
variable (19). Second, the scores on the ODSIS in the depression
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TABLE 5 | Statistics to assess the diagnostic accuracy of the ODSIS scores.
ODSIS
score
Se Sp PPV NPV J IU ER CZ
1 0.950 0.429 0.827 0.750 0.379 0.521 0.573 0.408
2 0.921 0.514 0.845 0.692 0.435 0.407 0.492 0.473
3 0.851 0.571 0.851 0.571 0.422 0.280 0.454 0.486
4 0.792 0.629 0.860 0.512 0.421 0.253 0.425 0.498
5 0.743 0.800 0.915 0.519 0.543 0.131 0.326 0.594
6 0.663 0.886 0.944 0.477 0.549 0.223 0.356 0.587
7 0.614 0.914 0.954 0.451 0.528 0.300 0.395 0.561
8 0.535 0.914 0.947 0.405 0.449 0.379 0.473 0.489
9 0.406 0.943 0.953 0.355 0.349 0.537 0.597 0.383
10 0.376 0.943 0.950 0.344 0.319 0.567 0.627 0.355
11 0.307 0.971 0.969 0.327 0.278 0.664 0.694 0.298
12 0.248 1 1 0.315 0.248 0.752 0.752 0.248
13 0.218 1 1 0.307 0.218 0.782 0.782 0.218
14 0.149 1 1 0.289 0.149 0.851 0.851 0.149
15 0.109 1 1 0.280 0.109 0.891 0.891 0.109
16 0.099 1 1 0.278 0.099 0.901 0.901 0.099
17 0.040 1 1 0.266 0.040 0.960 0.960 0.040
18 0 1 NA 0.257 0 1 1 0
Se, Sensitivity; Sp, Specificity; PPV, Positive Predictive Value; NPV, Negative Predictive
Value; J, Youden index; IU, Index of Union; ER, Closest to (0, 1) Criteria; CZ, Concordance
Probability Method; NA, Not Applicable.
sample were significantly higher than those in the anxiety sample.
These results suggest that, in this study, the ODSIS was able
to discriminate between depressive and anxiety disorders, a
property of the instrument that is also found in the validation
by Bentley et al. (19). Furthermore, patients with more comorbid
diagnoses had significantly higher levels of depression than those
without any comorbid disorder. These data are consistent with
the literature showing strong associations between comorbidity
and severity (10). These results demonstrate how the scale
performs in different populations, which is essential, given the
importance of developing brief measures that are applicable
across diverse clinical and research settings with distinct samples.
Because it is a very brief instrument, the ODSIS is expected
to be quite suitable for use in different settings and contexts,
such as research, primary care, clinical routine monitoring, and
epidemiological studies.
With regard to reliability, the ODSIS demonstrated excellent
internal consistency in the Spanish clinical sample (alpha =
0.93), consistent with previous validation studies (19, 21). Finally,
also, as in previous validations of the instrument (19, 21),
confirmatory factor analysis revealed a unidimensional factor
structure with strong factor loadings for all the items.
Regarding cutoff scores, a cutoff point of 5 was found to meet
three of the four criteria used to select the optimal cutoff point
[i.e., Index of Union, Closest to (0, 1) Criterion, and Concordance
Probability Method]. Thus, these outcomes suggest that this
score can be used as a cutoff point to discriminate patients
with clinical depressive symptoms from those with no clinical
depressive symptoms. These data might be useful, for instance,
for selecting patients with depressive symptoms for clinical trials.
The results obtained in this study using ROC analysis are not
consistent with prior validations of the instrument in clinical
populations because Bentley et al. (19) obtained a cutoff score
of 8, and Ito et al. (21) provided a cutoff score of 11.There
could be a number of reasons for these differences. For example,
participants in this study were classified based on a cutoff score
from a self-reported scale (BDI-II) [i.e., patients scoring ≥ 14
were classified as suffering from clinical levels of depression
(mild, moderate or severe depressive symptoms), whereas those
with scores under 14 were classified as not suffering from clinical
levels of depression (zero or minimal depressive symptoms)], the
samples had different characteristics (different clinical diagnoses,
different countries, etc.), and there were differences in the mean
ODSIS scores (7.83 for the Spanish clinical sample, 5.50 for the
U.S. clinical sample, and 6.51 for the Japanese clinical sample
examined here). These discrepancies might also account for the
differences between the cutoff scores obtained in the present
study and those from prior validations. Finally, the results by
Bentley et al. (19) and Ito et al. (21) are not consistent with each
other either. Thus, additional research is warranted to further
explore how the ODSIS performs in detecting patients with
clinical levels of depression.
The analysis of construct validity of the test scores yielded
evidence for relation with all other variables. As anticipated,
positive and relevant correlations were found between the ODSIS
and measures of negative affect, depressive symptoms, and
anxiety. Large and significant correlations between the ODSIS
and the BDI-II were interpreted as evidence of convergent
validity. Moreover, correlations between the ODSIS with anxiety
(OASIS, BAI) and affect (PANAS-P and PANAS-N) of lower
magnitude than with depression (BDI) were interpreted as
evidence of discriminant validity. Additionally, the positive and
large correlation observed between the ODSIS and the QLI
suggests the strong association between high levels of depression
and poorer quality of life. Overall, the results obtained in this
study support the construct validity of the ODSIS scores.
The strengths of this study are highlighted in the following
lines. First, this is the first study to evaluate the psychometric
properties of the ODSIS delivered online in a Spanish clinical
population. In clinical settings, the time that the clinicians
have available to assess patients is usually very limited. Brief
instruments like the ODSIS can help in the evaluation of the
severity and impairment caused by depression, making this task
simpler. Second, as mentioned above, depression is characterized
by high comorbidity rates (10), especially with the anxiety
disorders (44), and the present study presents data about how
the ODSIS works in patients, not only those with depression, but
also those with an anxiety disorder as a main diagnosis. Indeed,
the heterogeneity of the sample (patients with a range of anxiety
and depressive disorders) can help to increase the generalizability
of the results obtained in this study. Third, this study provides
further support for the literature on the ODSIS, suggesting that
it can be used in an online format without compromising its
psychometric properties, coinciding with the validation by (21).
Currently, as the field of Internet interventions expands, and
because the psychometric properties of the same instrument may
differ depending on the way it is administered (i.e., pencil and
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paper vs. online) (46), the need for studies to validate online
versions of well-established traditional scales is clear.
LIMITATIONS
This study has limitations that should be mentioned. First, even
though the BDI-II is a well-established measure and one of
the more widespread scales for the assessment of depression
(47, 48), we did not follow the optimum approach for the
calculation of the ROC curve because the classification of
subjects was based on a cutoff from a scale (BDI-II) rather
than a group of healthy control individuals. Therefore, caution
should be taken when using the cutoff score obtained in
this study. Second, the convergent validity of the ODSIS was
evaluated in relation to only one measure of depression (BDI-
II). Although it would have been desirable to include other
depression scales to more in depth explore the convergent
validity of the ODSIS scores, this was not possible because all
the participants in this study were referred from clinical trials
where the selection of assessment instruments was already pre-
determined. Finally, we did not evaluate the test-retest reliability
of the ODSIS.
CONCLUSIONS AND FUTURE
DIRECTIONS
To conclude, the results obtained in this study support the
internal consistency, factorial structure, and construct validity of
the ODSIS delivered online in a Spanish clinical sample with a
range of depressive and anxiety disorders, consistent with those
obtained in prior validations of the scale (16, 18).
Future validations of the ODSIS in Spanish clinical patients
are warranted to more precisely explore cutoff scores in a
sample of healthy control individuals. In addition, because there
is disparity between the cutoff scores obtained in this study
(ODSIS = 5) and those obtained in previous validations of
the ODSIS, more research is needed to replicate these findings.
Another important aspect is that, given that the ODSIS focuses
on depression-related severity and impairment, main targets
of any psychological or psychiatric intervention, future studies
should analyze the scale’s sensitivity to change, i.e., how the scale
performs as a treatment outcome measure. Finally, although
the sample used in this study was rather heterogeneous, it was
restricted to patients with depressive and anxiety disorders.
Therefore, further research is warranted to analyze the validity
and reliability of the ODSIS in more severe patients (e.g., bipolar
or psychotic disorders).
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